Primary rhegmatogenous retinal detachment: evaluation of a minimally restricted face-down positioning after pars plana vitrectomy and gas tamponade.
flexible postoperative positioning
retinal detachment
vitrectomy
Journal
International journal of ophthalmology
ISSN: 2222-3959
Titre abrégé: Int J Ophthalmol
Pays: China
ID NLM: 101553860
Informations de publication
Date de publication:
2021
2021
Historique:
received:
29
04
2020
accepted:
06
11
2020
entrez:
21
6
2021
pubmed:
22
6
2021
medline:
22
6
2021
Statut:
epublish
Résumé
To evaluate the safety and efficacy of a minimally restricted face-down postoperative positioning following pars plana vitrectomy (PPV) with gas tamponade for primary rhegmatogenous retinal detachment (RRD). Patients with primary RRD treated with PPV and gas tamponade and followed up for at least 6mo were selected for the study. All phakic eyes underwent simultaneous cataract surgery. The patients were required to be in a postoperative position that prevented downward flow of retinal tears. Patients with macular detachment were positioned face-down for only a couple of hours. The patients were assessed for preoperative and postoperative best-corrected visual acuity (BCVA), anatomical retinal reattachment rate, and postoperative complications. In total, 40 eyes of 39 patients with primary RRD were included in the study. A single tear was present in 30 eyes (75.0%), multiple retinal tears were present in nine eyes (22.5%), and oral dialysis was present in one eye (2.5%). The anatomical success rate was 90.0% (36 cases) after the primary surgery, and the final anatomical success rate was 100%. The BCVA improved significantly ( A minimally restricted face-down and flexible postoperative positioning after PPV and gas tamponade for primary RRD is effective and safe.
Identifiants
pubmed: 34150551
doi: 10.18240/ijo.2021.06.21
pii: ijo-14-06-936
pmc: PMC8165620
doi:
Types de publication
Journal Article
Langues
eng
Pagination
936-939Informations de copyright
International Journal of Ophthalmology Press.
Références
Int J Ophthalmol. 2019 Apr 18;12(4):660-667
pubmed: 31024823
J Ophthalmol. 2018 Nov 18;2018:8606494
pubmed: 30581605
Acta Ophthalmol. 2011 Jun;89(4):365-8
pubmed: 19860785
Ophthalmologica. 2018;240(1):1-7
pubmed: 29669355
Graefes Arch Clin Exp Ophthalmol. 2013 Feb;251(2):485-90
pubmed: 22588289
Taiwan J Ophthalmol. 2018 Oct-Dec;8(4):222-236
pubmed: 30637194
Br J Ophthalmol. 2015 Feb;99(2):236-9
pubmed: 25147367
Case Rep Ophthalmol. 2019 Jun 14;10(2):200-204
pubmed: 31692601
Ophthalmol Retina. 2019 May;3(5):388-392
pubmed: 31044728
Tohoku J Exp Med. 2019;248(3):159-168
pubmed: 31308289
Graefes Arch Clin Exp Ophthalmol. 2017 Sep;255(9):1749-1756
pubmed: 28608271
Curr Opin Ophthalmol. 2016 Mar;27(2):125-31
pubmed: 26595848
Ophthalmic Res. 2014;51(1):15-31
pubmed: 24158005
Clin Ophthalmol. 2018 Nov 14;12:2323-2329
pubmed: 30532517
BMC Ophthalmol. 2019 Dec 21;19(1):265
pubmed: 31864333
Retin Cases Brief Rep. 2019 Summer;13(3):266-268
pubmed: 28358743
BMC Ophthalmol. 2019 Jan 28;19(1):34
pubmed: 30691441
Mediators Inflamm. 2013;2013:857380
pubmed: 24227910
Acta Ophthalmol. 2012 Dec;90(8):744-9
pubmed: 21955606
J Ophthalmol. 2017;2017:5760173
pubmed: 28409022
Retina. 2015 May;35(5):892-8
pubmed: 25635574
BMC Ophthalmol. 2018 Dec 14;18(1):322
pubmed: 30547840
Acta Ophthalmol. 2016 Jun;94(4):326-33
pubmed: 26385613
Arch Ophthalmol. 2011 Aug;129(8):1109-10; author reply 1110
pubmed: 21825208
Br J Ophthalmol. 2013 Jan;97(1):80-2
pubmed: 23104901
PLoS One. 2018 Jan 26;13(1):e0191531
pubmed: 29373582